Caris Life Sciences, Inc. (CAI)

NASDAQ: CAI · Real-Time Price · USD

19.24

+0.93 (5.08%)

At close: Feb 26, 2026, 4:00 PM EST

22.00

+2.76 (14.35%)

After-hours: Feb 26, 2026, 4:48 PM EST

Caris Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Feb '26 Feb 26, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	5,429	-	-	-
Enterprise Value	5,100	-	-	-
Debt / Equity Ratio	0.89	-1.53	-11.04	1.08
Net Debt / Equity Ratio	-0.69	-1.29	-4.86	-0.55
Net Debt / EBITDA Ratio	6.21	-1.72	-0.35	0.52
Net Debt / FCF Ratio	23.47	-1.41	-0.32	0.42
Asset Turnover	-	1.09	0.54	-
Inventory Turnover	-	5.24	4.48	-
Quick Ratio	9.09	0.93	1.86	3.29
Current Ratio	9.93	1.30	2.55	3.77
Return on Equity (ROE)	-	-	-293.82%	-
Return on Assets (ROA)	-	-42.48%	-35.34%	-
Return on Capital Employed (ROCE)	-8.90%	-144.20%	-100.60%	-54.40%
Buyback Yield / Dilution	-201.21%	-1.59%	-4.73%	-

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q